Sreedhar Billakanty, MD
Clinical Cardiac Electrophysiology · Columbus, OHNPI 1760539985
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Atricure, Inc. at 33.5% of the total.
Across 272 payments — averaging $235.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$22K
- Biosense Webster, Inc.$16K
- Medtronic$12K
- Medical Device Business Services, Inc.$7K
- Boston Scientific$5K
- Abbott$1K
- plus $688 from 9 others
Across 54 payments — averaging $7316.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Adagio Medical, Inc.$175K
- Atricure, Inc.$128K
- Medtronic$92K
What the payments were for
- Consulting fees$35,15055%
- Speaking & faculty fees$8,66014%
- Travel & lodging$9,49015%
- Food & beverage$10,83717%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 50 | $21,507 |
| Biosense Webster, Inc. | 62 | $16,478 |
| Medtronic(2 entities) | 54 | $11,629 |
| Medical Device Business Services, Inc. | 8 | $7,313 |
| Boston Scientific | 68 | $5,086 |
| Abbott | 12 | $1,435 |
| Philips North America LLC | 4 | $263 |
| Acutus Medical, Inc. | 1 | $130 |
| Impulse Dynamics (USA) Inc. | 1 | $79 |
| Johnson & Johnson | 4 | $60 |
| Pfizer | 3 | $47 |
| Kestra Medical Technology Services, Inc. | 1 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Cardiva Medical, Inc. | 1 | $30 |
| Cook Medical LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$19,649
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$15,456
- ATRICLIP LAA EXCLUSION SYSTEM$10,484
- AFFERA MAPPING SYSTEM$4,800
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$3,734
- Carto 3 System$1,500
- EPI-SENSE GUIDED COAGULATION SYS$1,241
- AVEIR$901
- GENERAL - THERAPIES$488
- EVERA MRI XT DR SURESCAN$401
- WATCHMAN FLX$379
- Rhythmia Mapping System$309
- EMBLEM MRI S-ICD$234
- AMPLATZER AMULET$207
- Evera$202
- ATRICURE SYNERGY ABLATION SYSTEM$145
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$140
- Micra$126
- Viva$114
- GENERAL EP$108
How this compares
$64,136 in reported general payments places this provider in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
See all clinical cardiac electrophysiology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 588 | $593,777 |
| XareltoRivaroxaban | 157 | $170,961 |
| Dofetilide | 93 | $35,736 |
| Flecainide Acetate | 219 | $11,228 |
| Propafenone Hcl ErPropafenone Hcl | 25 | $6,878 |
| Metoprolol Succinate | 493 | $6,654 |
| Amiodarone Hcl | 320 | $6,109 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 15 | $5,294 |
| Propafenone Hcl | 56 | $3,795 |
| SotalolSotalol Hcl | 124 | $2,967 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 76 | $1,990 |
| Metoprolol Tartrate | 169 | $1,178 |
| Bumetanide | 50 | $888 |
| Potassium Chloride | 40 | $834 |
| Carvedilol | 53 | $455 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $47 | $593,777588 claims |
| Johnson & JohnsonXarelto | $60 | $170,961157 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 159 clinical cardiac electrophysiology providers in Ohio.
Other clinical cardiac electrophysiology in Columbus
- Anish AminColumbus$1.1M
- John HummelColumbus$275K
- Auroa BadinColumbus$188K
- Ralph AugostiniColumbus$174K
- David NemerColumbus$97K
- Eugene FuColumbus$96K
- Ankur ShahColumbus$75K
- Sampath GundaColumbus$73K
- Salvatore SavonaColumbus$49K
- Natee SirinvaravongColumbus$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.